An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension

Boehringer Ingelheim

Status: Completed

Conditions: Hypertension

Treatments: Drug: telmisartan/telmisartan + HCTZ (Hydrochlorothiazide)

Study type: Observational

Funder types: Industry

Identifiers

NCT00904215

502.487

Details and patient eligibility

About

An observational study to investigate the efficacy, safety, tolerability and the effect on quality of life of Telmisartan (Micardis) and Telmisartan with HCTZ (Micardis Plus) in patients with hypertension

Enrollment: 1,095 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Ability to provide written/verbal informed consent in accordance with GCP (Good Clinical Practice) and local legislation

2. Patients aged 18 ~ under 80

3. Hypertension as described below:

   • Newly diagnosed patients with hypertension
   • Patients with current antihypertensive therapy

Exclusion criteria

1. Female subjects who are breastfeeding, pregnant or who plan to be pregnant during the study
2. Known or suspected secondary hypertension(e.g. pheochromocytoma)
3. Patients who have been treated with telmisartan prior to the acquisition of informed consent (including verbal informed consent)